Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science

被引:34
作者
Salter, Brian [1 ]
Zhou, Yinhua [1 ]
Datta, Saheli [1 ]
机构
[1] Kings Coll London, Dept Polit Econ, London WC2 2LS, England
关键词
Health consumers; Market; Hegemony; Political economy; Biomedical innovation; Stem cells; Governance; Bioethics; MEDICAL TOURISM; PATIENT; THERAPY; BIOETHICS; CARE; IDEOLOGY; STRUGGLE; MODEL; WORLD; NEED;
D O I
10.1016/j.socscimed.2015.03.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The global political economy of stem cell therapies is characterised by an established biomedical hegemony of expertise, governance and values in collision with an increasingly informed health consumer demand able to define and pursue its own interest. How does the hegemony then deal with the challenge from the consumer market and what does this tell us about its modus operandi? In developing a theoretical framework to answer these questions, the paper begins with an analysis of the nature of the hegemony of biomedical innovation in general, its close relationship with the research funding market, the current political modes of consumer incorporation, and the ideological role performed by bioethics as legitimating agency. Secondly, taking the case of stem cell innovation, it explores the hegemonic challenge posed by consumer demand working through the global practice based market of medical innovation, the response of the national and international institutions of science and their reassertion of the values of the orthodox model, and the supporting contribution of bioethics. Finally, the paper addresses the tensions within the hegemonic model of stem cell innovation between the key roles and values of scientist and clinician, the exacerbation of these tensions by the increasingly visible demands of health consumers, and the emergence of political compromise. (C) 2015 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:156 / 163
页数:8
相关论文
共 88 条
[11]   Bioethics and ideology [J].
Callahan, D .
HASTINGS CENTER REPORT, 2006, 36 (01) :3-3
[12]   STEM CELL TREATMENTS IN CHINA: RETHINKING THE PATIENT ROLE IN THE GLOBAL BIO-ECONOMY [J].
Chen, Haidan ;
Gottweis, Herbert .
BIOETHICS, 2013, 27 (04) :194-207
[13]   International Stem Cell Tourism and the Need for Effective Regulation Part II: Developing Sound Oversight Measures and Effective Patient Support [J].
Cohen, Cynthia B. ;
Cohen, Peter J. .
KENNEDY INSTITUTE OF ETHICS JOURNAL, 2010, 20 (03) :207-230
[14]  
Connell J, 2011, MED TOURISM
[15]  
Cooksey D., 2006, REV UK HLTH RES FUND
[16]  
Cortez N, 2008, INDIANA LAW J, V83, P71
[17]  
Cox RobertW., 1983, MILLENNIUM-J INT ST, V12, P162, DOI [DOI 10.1177/03058298830120020701, 10.1177/03058298830120020701]
[18]   Towards the applied: the construction of ethical positions in stem cell translational research [J].
Cribb, Alan ;
Wainwright, Steven ;
Williams, Clare ;
Farsides, Bobbie ;
Michael, Mike .
MEDICINE HEALTH CARE AND PHILOSOPHY, 2008, 11 (03) :351-361
[19]  
Dedmon RE, 2009, ASIAN BIOMED, V3, P339
[20]  
Deloitte, 2009, MED TOUR UPD IMPL